Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Golden Throat Holdings Group Co Ltd ( (HK:6896) ) just unveiled an update.
Golden Throat Holdings Group Company Limited has declared a final ordinary cash dividend of HKD 0.34 per share for the financial year ended 31 December 2025, payable in Hong Kong dollars. Shareholder approval, ex-dividend date, book closure period, record date and related timetable details have yet to be announced.
The dividend is scheduled to be paid on 26 June 2026, with Computershare Hong Kong Investor Services Limited acting as share registrar and no withholding tax indicated for the distribution. The move underscores the company’s continued commitment to returning cash to shareholders and may signal management’s confidence in its earnings and cash flow outlook.
The most recent analyst rating on (HK:6896) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on Golden Throat Holdings Group Co Ltd stock, see the HK:6896 Stock Forecast page.
More about Golden Throat Holdings Group Co Ltd
Golden Throat Holdings Group Company Limited is a Hong Kong-listed company engaged in the manufacture and sale of throat lozenges and related healthcare products, with its shares traded under stock code 06896. The group focuses on consumer health products in Greater China and other markets, positioning itself as a branded player in the over-the-counter healthcare segment.
Average Trading Volume: 811,158
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.64B
See more data about 6896 stock on TipRanks’ Stock Analysis page.